tiprankstipranks
MiNK Therapeutics (INKT)
NASDAQ:INKT
US Market

MiNK Therapeutics (INKT) Similar Stocks

Compare
143 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
MiNK Therapeutics
$8.75
$34.71M
-37.24%
3 Buy
0 Hold
0 Sell
Strong Buy
Tempest Therapeutics
$0.61
$32.68M
-86.36%
4 Buy
0 Hold
0 Sell
Strong Buy
Kezar Life Sciences
$4.12
$32.88M
-49.82%
3 Buy
1 Hold
0 Sell
Strong Buy
ALX Oncology Holdings
$0.53
$28.46M
-95.42%
4 Buy
2 Hold
0 Sell
Moderate Buy
Surrozen
$11.74
$38.52M
-3.00%
1 Buy
0 Hold
0 Sell
Moderate Buy
Connect Biopharma Holdings
$0.59
$32.66M
-65.00%
1 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INKT
MiNK Therapeutics
8.41
-7.19
-46.09%
TPST
Tempest Therapeutics
0.61
-3.11
-83.60%
KZR
Kezar Life Sciences
4.12
-3.86
-48.37%
ALXO
ALX Oncology Holdings
0.52
-11.71
-95.75%
SRZN
Surrozen
10.99
-0.14
-1.26%
CNTB
Connect Biopharma Holdings
0.63
-1.51
-70.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis